Galena Biopharma, a biopharmaceutical company focused on developing and commercializing targeted oncology treatments to address major unmet medical needs and advance cancer care, today announced that its president and chief executive officer, Mark J. Ahn, Ph.D., will be presenting a corporate update at the 20th Annual NewsMakers in the Biotech Industry Conference. The presentation will take place this Friday at 3:00 p.m. ET.
Those unable to attend the presentation in person, which will be delivered at the Millennium Broadway Hotel in New York, NY, can access a webcast available on the Investors section of the company’s website at www.galenabiopharma.com.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment